Qyuns Therapeutics Co Ltd (2509.HK)

HKD 11.24

(1.81%)

Operating Expenses Summary of Qyuns Therapeutics Co Ltd

  • Qyuns Therapeutics Co Ltd's latest annual operating expenses in 2023 was 519.26 Million CNY , up 55.63% from previous year.
  • Qyuns Therapeutics Co Ltd's latest quarterly operating expenses in 2024 Q2 was 103.49 Million CNY , down 0.0% from previous quarter.
  • Qyuns Therapeutics Co Ltd reported a annual operating expenses of 352.67 Million CNY in annual operating expenses 2022, up 67.17% from previous year.
  • Qyuns Therapeutics Co Ltd reported a annual operating expenses of 210.96 Million CNY in annual operating expenses 2021, down 0.0% from previous year.
  • Qyuns Therapeutics Co Ltd reported a quarterly operating expenses of 103.49 Million CNY for 2024 Q1, down -28.7% from previous quarter.
  • Qyuns Therapeutics Co Ltd reported a quarterly operating expenses of 145.15 Million CNY for 2023 Q4, up 23.11% from previous quarter.

Annual Operating Expenses Chart of Qyuns Therapeutics Co Ltd (2023 - 2021)

Historical Annual Operating Expenses of Qyuns Therapeutics Co Ltd (2023 - 2021)

Year Operating Expenses Operating Expenses Growth
2023 519.26 Million CNY 55.63%
2022 352.67 Million CNY 67.17%
2021 210.96 Million CNY 0.0%

Peer Operating Expenses Comparison of Qyuns Therapeutics Co Ltd

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD -59.749%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD 29.759%